HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Lowers Price Target to $1.5
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained its Buy rating on Applied DNA Sciences (NASDAQ:APDN) but has significantly lowered the price target from $7 to $1.5.
June 10, 2024 | 11:48 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HC Wainwright & Co. has maintained its Buy rating on Applied DNA Sciences but has significantly lowered the price target from $7 to $1.5.
The significant reduction in the price target from $7 to $1.5 suggests a less optimistic outlook for Applied DNA Sciences, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100